The role of cytokines in infectious sinusitis and nasal polyposis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 1, 1998, Pages 2-13

  Bachert, C ^a,c   Wagenmann, M ^b   Rudack, C ^b   Hopken K ^b   Hillebrandt, M ^b   Wang, D ^a   Van Cauwenberge, P ^a  

^a GHENT UNIVERSITY   (Belgium)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL INFECTION; COMMON COLD; HOST RESISTANCE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INTERFERON PRODUCTION; NOSE POLYP; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; SINUSITIS; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

EID: 0031984027     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb03767.x     Document Type: Review

References (99)

1. Moss AJ, Parsons VL. Current estimates from the National Health Interview Survey, United States - 1985. In: Hyattsville, Maryland: National Center for Health Statistics, DHHS publication no. (PHS) 68-1588 (Vital and Health Statistics; series 10; no. 160), 1986:66-7.
2. Settipane GA, Chaffee FH. Nasal polyps. Am J Rhinol 1987;1:119-26.
3. Gwaltney JM. Microbiology of sinusitis. In: Druce HM, editor. Sinusitis: pathophysiology and treatment. New York: Marcel Dekker, 1994:41-56.
4. Baraniuk JN. Physiology of sinusitis. In: Druce HM, editor. Sinusitis: pathophysiology and treatment. New York: Marcel Dekker 1994:19-39.
5. Stammberger H. Endoscopic endonasal surgery - concepts in treatment of recurring rhinosinusitis. I. Anatomic and pathophysiological considerations. Otolaryngol Head Neck Surg 1986;94:143-7.
6. Mygind N. Nasal polyposis. J Allergy Clin Immunol 1990; 86(6, pt 1):827-9.
7. Tos M, Sasaki Y, Ohnishi M, Larsen P, Drake LA. Pathogenesis of nasal polyps. Rhinol Suppl 1992;14:181-5.
8. Tokushige E, Itoh K, Ushikai M, Katahira S, Fukuda K. Localization of IL-1β mRNA and cell adhesion molecules in the maxillary sinus mucosa of patients with chronic sinusitis. Laryngoscope 1994;104:1245-50.
9. Lund VJ, Henderson B, Song Y. Involvement of cytokines and vascular adhesion molecules in the pathophysiology of fronto-ethmoidal mucoceles. Acta Otolaryngol (Stockh) 1993;113:540-6.
10. Takeuchi K, Yuta A, Sakakura Y. Interleukin-8 expression in chronic sinusitis. Am J Otolaryngol 1995;16:98-102.
11. Suzuki H, Takahashi Y, Wataya H, et al. Mechanism of neutrophil recruitment induced by IL-8 in chronic sinusitis. J Allergy Clin Immunol 1996;98:659-70.
12. Hamilos DL, Leung DY, Wood R, et al. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol 1993;92: 39-48.
13. Costa JJ, Matossian K, Resnick MB, et al. Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J Clin Invest 1993;91:2673-84.
14. Ohno I, Lea RG, Flanders KC, et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest 1992;89:1662-8.
15. Finotto S, Ohno I, Marshall JS, et al. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994;153:2278-89.
16. Elovic A, Wong DT, Weller PF, Matossian K, Galli SJ. Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J Allergy Clin Immunol 1994;93:864-9.
17. Bachert C, Hauser U, Wagenmann M, Brandt A, Däter I, Prem B. Interleukin-5 protein is detected in nasal polyps [Abstract]. J Allergy Clin Immunol 1995;95:389.
18. Gwaltney JM, Phillips CD, Riker DK. Computerized tomography study of the common cold. N Engl J Med 1994;330:25-30.
19. Röseler S, Holtappels G, Wagenmann M, Bachert C. Elevated levels of IL-1β, IL-6 and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolaryngol 1995;252: S61-3.
20. Proud D, Naclerio RM, Gwaltney JM, Hendley JO. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis 1990;161:120-3.
21. Bachert C, Wagenmann M, Hauser U. Proinflammatory cytokines: measurement in nasal secretion and induction of adhesion receptor expression. Int Arch Allergy Immunol 1995;107:106-8.
22. Winther B, Brofeldt S, Christensen B, Mygind N. Light and scanning electron microscopy of nasal biopsy material from patients with naturally acquired common colds. Acta Otolaryngol 1984;97:309-18.
23. Proud D, Gwaltney JM, Hendley JO, Dinarello CA, Gillis S, Schleimer RP. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus cold. J Infect Dis 1994;169:1007-13.
24. Noah TL, Henderson FW, Wortman IA, et al. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 1995;171:584-92.
25. Hussell T, Spender LC, Georgiou A, O'Garra A, Openshaw PJ. TH1 and TH2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J Gen Virol 1996;77:2447-55.
26. Linden M, Greiff L, Andersson M, et al. Nasal cytokines in common cold and allergic rhinitis. Clin Exp Allergy 1995;25:166-72.
27. De Maeyer E, De Maeyer-Guignard J. Interferons. In: Thomson AW, editor. The cytokine handbook. London: Academic Press, 1994:265-88.
28. Mosmann TR. Interleukin-10. In: Thomson AW, editor. The cytokine handbook. London: Academic Press, 1994: 223-38.
29. Greve JM, Davis G, Meyer AM, et al. The major human rhinovirus receptor is ICAM-1. Cell 1989;56:839-47.
30. Marlin SD, Staunton DE, Springer TA, Stratowa C, Sommergruber W, Marluzzi VJ. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature 1990;344:70-2.
31. Bachert C, Hauser U, Prem B, Rudack C, Ganzer U. Proinflammatory cytokines in allergic rhinitis. Eur Arch Otorhinolaryngol Suppl 1995;1:844-9.
32. Baroody FM, Lee BJ, Lim MC, Bochner BS. Implicating adhesion molecules in nasal allergic inflammation. Eur Arch Otorhinolaryngol 1995;252:S50-8.
33. van Damme J. Interleukin-8 and related molecules. In: Thompson AW, editor. The cytokine handbook. London: Academic Press, 1991:201-14.
34. Lund VJ, Kennedy DW. Quantification for staging sinusitis. Ann Otol Rhinol Laryngol 1995;104 Suppl 167: 17-21.
35. van Cauwenberge P, Ingels K. Effects of viral and bacterial infection on nasal and sinus mucosa. Acta Otolaryngol (Stockh) 1996;116:316-21.
36. Stierna P, Carlsoo B. Histopathological observations in chronic maxillary sinusitis. Acta Otolaryngol (Stockh) 1990;110:450-8.
37. Nishimoto K, Kotaro U, Teruhiko H, Shun JC, Sakakura Y. Lymphocyte subsets in maxillary mucosa in chronic inflammation. Acta Otolaryngol (Stockh) 1988;106:291-8.
38. Georgitis JW, Matthews BL, Stone B. Chronic sinusitis: characterization of cellular influx and inflammatory mediators in sinus lavage fluid. Int Arch Allergy Immunol 1995; 106:416-21.
39. Harlin SL, Ansel DG, Lane SR, et al. A clinical and pathologic study of chronic sinusitis: the role of the eosinophil. J Allergy Clin Immunol 1988;81:867-75.
40. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Phagocytosing neutrophils produce and release high amounts of NAP-1/IL-8. J Exp Med 1991; 173:771-4.
41. Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor α. Proc Natl Acad Sci U S A 1990;87:6758-61.
42. Lindemann A, Riedel D, Oster W, Meuer SC, Blohm D, Mertelsmann RH. Granulocyte/macrophage colony-stimulating factor induces interleukin-1 production by human polymorphonuclear neutrophils. J Immunol 1988; 140:837-9.
43. Schrader JW. Interleukin-3. In: Thomson A, editor. The cytokine handbook. London: Academic Press, 1994:81-98.
44. Persson CGA, Erjefält JS, Andersson M, et al. Epithelium, microcirculation and eosinophils - new aspects of the allergic airway in vivo. Allergy 1997;52:241-55.
45. Bachert C. The role of allergy in chronic sinusitis. In: van Cauwenberge P, Wang D, Ingels K, Bachert C, editors. The nose. Amsterdam: Kugler, 1997 (in press).
46. Stoop AE, van der Heijden HA, Biewenga J, van der Baan S. Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study. J Allergy Clin Immunol 1993; 91:616-22.
47. Jahnsen FL, Halstensen TS, Brandtzaeg P. Erroneous immunohistochemical application of monoclonal antibody EG2 to detect cellular activation. Lancet 1994;344:1514-15.
48. Liu CM, Shun CT, Hsu MM. Lymphocyte subsets and antigen-specific IgE antibody in nasal polyps. Ann Allergy 1994;72:19-24.
49. Liu Y, Hamaguchi Y, Taya M, Sakakura Y. Quantification of interleukin-1 in nasal polyps from patients with chronic sinusitis. Eur Arch Otorhinolaryngol 1993;250:123-5.
50. Hamaguchi Y, Suzumura H, Arima S, Sakakura Y. Quantitation and immunocytological identification of interleukin-1 in nasal polyps from patients with chronic sinusitis. Int Arch Allergy Immunol 1994;104:155-9.
51. Ohno I, Lea R, Finotto S, et al. Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils in nasal polyposis. Am J Respir Cell Mol Biol 1991;5:505-10.
52. Vanchieri C, Ohtoshi T, Cox G, et al. Neutrophilic differentiation induced by human upper respiratory airway fibroblast-derived granulocyte/macrophage colony-stimulating factor (GM-CSF). Am J Respir Cell Mol Biol 1991;4:11-17.
53. Bachert C, Prem B, Däter I. Zytokine in der Polyposisforschung - eine neue Dimension. Allergologie 1994;12: 578-81.
54. Bachert C, Wagenmann M, Hauser U, Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 1997;99:837-42.
55. Ebisawa M, Bochner BS, Georas SN, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration. J Immunol 1992;149:4021-8.
56. Sehmi R, Cromwell O, Wardlaw J, Moqbel R, Kay B. Interleukin-8 is a chemoattractant for eosinophils purified from subjects with a blood eosinophilia but not from healthy subjects. Clin Exp Allergy 1994;23:1027-31.
57. Alam R, Stafford S, Forsythe P, Harrison R, Faubion D, Lett Brown MA. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993;150:3442-8.
58. Kapp A, Zeck-Kapp G, Czech W, Schöpf E. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF. J. Invest Dermatol 1994:102:906-14.
59. Ebisawa M, Liu MC, Yamada T, et al. Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines. J Immunol 1994;152:4590-6.
60. Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol 1994;153:2153-60.
61. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247(4941): 456-9.
62. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. Immunol 1992;148:1086-92.
63. Jose PJ, Griffiths-Johnson DA, Collins PD, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1993;179:881-7.
64. Ponath PD, Qin S, Ringler DJ, et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604-12.
65. Marfaing-Koka A, Devergene O, Gorgone G, et al. Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction by IFN-gamma plus TNF-α and inhibition by IL-4 and IL-13. J Immunol 1995;154:1870-8.
66. Beck LA, Schall TJ, Beall LD, Leopold D, Bickel C, Baroody F. Detection of the chemokine RANTES and activation of vascular endothelium in nasal polyps [Abstract]. J Allergy Clin Immunol 1994;93:234.
67. Maune S, Meyer JE, Sticherling M, Fölster-Holst P, Schröder JM. Eosinophilen-chemotaktische Aktivität in der Chemokinfraktion von Nasenpolypen. Allergologie 1996;19:230-3.
68. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996; 2:449-56.
69. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995;182:1169-74.
70. Kitaura M, Nakajama T, Imai T, et al. Molecular cloning of human eotaxin, an eosinophil-specific CC chemokine. and identification of a specific receptor, CC chemokine receptor 3. J Biol Chem 1996;271:7725-30.
71. Elsner J, Hochstetter R, Kimmig D, Kapp A. Human eotaxin represents a potent activator of the respiratory burst in human eosinophils. Eur J Immunol 1996;26:1919-25.
72. Jahnsen FL, Haraldsen G, Aanesen JP, Haye R, Brandtzaeg P. Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Mol Biol 1995;12:624-32.
73. Nonaka M, Nonaka R, Wooley K, et al. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissue. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils. J Immunol 1995; 155:3234-44.
74. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;99:3902-8.
75. Hamilos DL, Leung DY, Wood R, et al. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am J Respir Cell Mol Biol 1996;15:443-50.
76. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992;146:109-14.
77. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I. Role of vascular cell adhesion molecule-1/very late activation antigen-4 and intercellular adhesion molecule-1/ lymphocyte function-associated antigen-1 interactions in antigen-induced eosinophil and T-cell recruitment into the tissue. J Exp Med 1994;179:1145-54.
78. Montefort S, Feather IH, Wilson SJ, et al. The expression of leucocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis. Am J Respir Cell Mol Biol 1992; 7:393-8.
79. Symon FA, Walsh GM, Watson SR, Wardlaw AJ. Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent. J Exp Med 1994;180:371-6.
80. Hamilos DL, Leung DJ, Wood R, et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995;96:537-44.
81. Min YG, Chung JW, Shin JS, Chi JG. Histologic structure of antrochoanal polyps. Acta Otolaryngol (Stockh) 1995;115:543-7.
82. Weller PF. The immunobiology of cosinophils. N Engl J Med 1991;324:1110-18.
83. Her E, Frazer J, Austen KF, Owen WF. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorlicoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest 1991;88:1982-9.
84. Simon HU, Blaser K. Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol Today 1995;16:53-5.
85. Yamaguchi Y, Hayashi Y, Sugama Y, et al. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J Exp Med 1988;167: 1737-42.
86. Broide DH, Paine MM, Firestein G. Eosinophils express IL-5 and GM-CSF mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992;90:1414-18.
87. Desreumaux P, Janin A, Dubucquoi S, et al. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 1993;82:1553-60.
88. Devos R, Guisez Y, van der Heyden J, Tavernier J. Interleukin-5 and its receptor: a drug target for eosinophilia associated with chronic disease. J Leukoc Biol 1995;57: 813-19.
89. Mauser PJ, Pitman AM, Fernandez X, et al. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 1995;152:467-72.
90. Okudaira H, Mori A, Kaminuma O, Suko M. IL-5 regulation - a new approach to allergy therapy. Allergy Clin Immunol Int 1996;8:172-9.
91. Devos R, Plaetnick G, van der Heyden J, et al. Molecular basis of a high affinity murine interleukin-5 receptor. EMBO J 1991;10:2133-7.
92. Tavernier J, Devos R, Tuypens T, et al. Human high affinity interleukin-5 receptor (IL-5R) is composed of an IL-5-specific α chain and a β chain shared with the receptor for GM-CSF. Cell 1991;66:1175-84.
93. Tavernier J, Tuypens T, Plaetnick G, Cornelis S, Verhee A, Devos R. Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin-5 receptor α-subunit. Proc Natl Acad Sci U S A 1992;89:7041-5.
94. Venge P. Soluble markers of allergic inflammation. Allergy 1994;49:1-8.
95. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
96. Gleich GJ, Abu-Ghazaleh RI, Glitz DG. Eosinophil granule proteins: structure and function. In: Gleich GJ, Kay AB, editors. Eosinophils in allergy and inflammation. New York: Marcel Dekker, 1994:1-20.
97. Flavahan NA, Slifman NR, Gleich GJ, Vanhoutte PM. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. Am Rev Respir Dis 1988;138:685-8.
98. Hastie AT, Loegering DA, Gleich GJ, Kueppers F. The effect of purified human eosinophil cationic protein on mammalian ciliary activity. Am Rev Respir Dis 1987;135: 848-55.
99. Tottrup A, Fredens K, Funch-Jensen P, Aggestrup S, Dahl R. Eosinophil infiltration in primary esophageal achalasia. A possible pathogenic role. Dig Dis Sci 1989;34:1894-9.